BALANCE
Thymosin Alpha-1
Immune resilience, reinforced.
Order Inclusions
What it does for you
- /01Studied for its interaction with T-cell and dendritic-cell signalling
- /02Examined in models of innate and adaptive immune coordination
- /03A 28-amino-acid peptide modelled on a naturally occurring thymic factor
- /04Presented for research use only, without clinical or dosing guidance
Batch Documentation
No current batch documents are published for this product.
Confirm current documentationThymosin Alpha-1 Research Notes
What is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1) is a synthetic 28-amino-acid peptide modelled on a naturally occurring thymic factor. It is studied as an immunomodulator: research examines how it may influence the coordination of immune signalling rather than treating it as a simple immune stimulant.
Its research profile spans innate and adaptive immune pathways. Published work has explored dendritic-cell maturation, T-cell activity, natural-killer-cell function, and cytokine signalling in laboratory models and defined clinical settings. Those research findings do not establish a treatment outcome for an individual product or person.
What the research shows
The evidence base includes mechanistic studies, preclinical models, and clinical research in specific contexts. Interpretation remains dependent on the study population and protocol, so GUARD is presented for research use only and without dosing or treatment guidance.
Immune cell signalling: Research has examined Tα1 in relation to dendritic cells, T cells, and natural killer cells — cell types that coordinate recognition and response within the immune system.
Cytokine regulation: Laboratory and clinical studies have explored its relationship with cytokine and chemokine signalling, an area of interest for understanding how immune responses are regulated rather than simply amplified.
Vaccine-response research: Tα1 has been investigated as an immune-response modifier and vaccine adjuvant in selected research settings. Results are context-specific and are not a substitute for approved medical guidance.
Evidence limits: Published findings are heterogeneous across diseases, populations, and protocols. This listing does not claim prevention, treatment, or protection against infection or any medical condition.
Reference: Hathaway D. et al. (2020). Thymosin alpha 1: A comprehensive review of the literature. World Journal of Virology, 9(5), 67–78. doi:10.5501/wjv.v9.i5.67.
Ordering Thymosin Alpha-1 in Bali
GUARD is supplied as a 10 mg research-use-only vial. Contact BioPepTech to confirm current availability and delivery options for your location. Keep the sealed vial refrigerated and protected from heat and direct light.
Common Questions
Q: Is GUARD intended for research use?
Yes. GUARD is presented as a research-use-only Thymosin Alpha-1 product. This page does not provide diagnostic, treatment, or dosing advice.
Q: What is Thymosin Alpha-1 studied for?
Research explores how Tα1 relates to immune-cell signalling, including dendritic-cell and T-cell activity, cytokine regulation, and immune-response coordination. Findings vary by model and research context.
Q: How should the vial be stored?
Keep the sealed vial refrigerated at 2–8°C, protected from heat and direct light. Follow product and batch-specific instructions for handling after reconstitution.